Aliment Pharmacol Ther
- ARATARI A, Scribano ML, Pugliese D, Baccolini V, et al
Crohn's disease after surgery: Changes in post-operative management strategies
over time and their impact on long-term re-operation rate-A retrospective
multicentre real-world study.
Aliment Pharmacol Ther. 2024 Apr 14. doi: 10.1111/apt.18001.
- KIM K, Park JJ, Yoon H, Lee J, et al
Application of clinical decision support tools for predicting outcomes with
vedolizumab therapy in patients with inflammatory bowel disease: A KASID
multicentre study.
Aliment Pharmacol Ther. 2024 Apr 14. doi: 10.1111/apt.17989.
BMC Gastroenterol
- MENESY A, Hammad M, Aref S, Abozeid FAM, et al
Level of interleukin 17 in inflammatory bowel disease and its relation with
disease activity.
BMC Gastroenterol. 2024;24:135.
- NOROUZKHANI N, Faramarzi M, Bahari A, Shirvani JS, et al
Inflammatory bowel disease patients' perspectives of non-medical needs.
BMC Gastroenterol. 2024;24:134.
Dig Dis Sci
- LAMICHHANE N, Melas N, Bergqvist V, Ekholm NP, et al
Real-World Outcomes of Patients Starting Intravenous and Transitioning to
Subcutaneous Vedolizumab in Inflammatory Bowel Disease.
Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08422.
- KANE K, Velayos FS, Lee JK, Cherny S, et al
A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of
Ulcerative Colitis.
Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08408.
- DJALAL A, Wong SY, Colombel JF, Ungaro R, et al
Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis.
Dig Dis Sci. 2024;69:1102-1104.
- CLINTON J, Motwani KK, Schwartz S, McCarthy P, et al
Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an
Acute Care Setting.
Dig Dis Sci. 2024;69:1105-1109.
- SINGH A, Mahajan R, Midha V, Kaur K, et al
Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided
Colitis and Pancolitis.
Dig Dis Sci. 2024;69:1389-1402.
- HUSSAIN N, Trivedi PJ
Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08262.
Eur J Gastroenterol Hepatol
- SUN Z, Cao L, Chen Y, Zhu W, et al
Long-term outcomes of intestinal penetrating Crohn's disease following successful
nonoperative management.
Eur J Gastroenterol Hepatol. 2024 Apr 5. doi: 10.1097/MEG.0000000000002775.
- TEPES K, Hanzel J, Stubljar D, Strmsek K, et al
Biological treatment approach to inflammatory bowel disease is similar in
academic and nonacademic centres - prime time for decentralisation of
inflammatory bowel disease care?
Eur J Gastroenterol Hepatol. 2024 Apr 2. doi: 10.1097/MEG.0000000000002771.
- WESTON F, Carter B, Powell N, Young AH, et al
Antidepressant treatment in inflammatory bowel disease: a systematic review and
meta-analysis.
Eur J Gastroenterol Hepatol. 2024 Apr 5. doi: 10.1097/MEG.0000000000002768.
Gastroenterology
- KEEFER L, Hashash JG, Szigethy E, Mayer EA, et al
AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease:
Commentary.
Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
- ZOLLNER A, Koch R, Jukic A, Pfister A, et al
Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two
years in patients with inflammatory bowel disease.
Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.
Inflamm Bowel Dis
- AL RADI ZMA, Prins FM, Collij V, Vich Vila A, et al
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy
Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up
Study.
Inflamm Bowel Dis. 2024 Apr 18:izae064. doi: 10.1093.
J Clin Gastroenterol
- KARIME C, Salazar M, Black CN, Caldera F, et al
In Patients With Inflammatory Bowel Disease, Racial Disparities Exist in Burden
of Vaccine-preventable Disease Hospitalizations and Outcomes.
J Clin Gastroenterol. 2024 Apr 16. doi: 10.1097/MCG.0000000000002005.
J Crohns Colitis
- BURTON-MURRAY H, Kiser K, Gurung J, Williams K, et al
Avoidant/restrictive food intake disorder symptoms are not as frequent as other
eating disorder symptoms when ulcerative colitis is in remission.
J Crohns Colitis. 2024 Apr 18:jjae052. doi: 10.1093.
- BROWN M, Dodd A, Shi F, Greenwood E, et al
Concordant B and T Cell Heterogeneity Inferred from the Multiomic Landscape of
Peripheral Blood Mononuclear Cells in a Crohn's Disease Cohort.
J Crohns Colitis. 2024 Apr 13:jjae055. doi: 10.1093.
Lancet Gastroenterol Hepatol
- PARKES GC, Hedin CRH
PANTS extension study: how best to use anti-TNF drugs in Crohn's disease.
Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00088.
- CHANCHLANI N, Lin S, Bewshea C, Hamilton B, et al
Mechanisms and management of loss of response to anti-TNF therapy for patients
with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort
study.
Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00044.
Mediators Inflamm
- HONG S, Wang H, Chan S, Zhang J, et al
Identifying Macrophage-Related Genes in Ulcerative Colitis Using Weighted
Coexpression Network Analysis and Machine Learning.
Mediators Inflamm. 2023;2023:4373840.
PLoS One
- WU H, Jiang F, Yuan W, Zhao Y, et al
Rauwolfia polysaccharide can inhibit the progress of ulcerative colitis through
NOS2-mediated JAK2/STAT3 pathway.
PLoS One. 2024;19:e0301660.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016